Effect of iPSC-derived NK cells with site-specific integration of CAR19 and IL24 at the rDNA locus on anti-tumor activity and proliferation. This is an ASCO Meeting Abstract from the ASCO Breakthrough ...
Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing innovative treatments for life-threatening immune and thrombotic conditions, today highlighted recent scientific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results